These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 13387613)

  • 21. Clinical experience with orinase.
    DUBE AH; FULMER HS; LLOYD CW
    Metabolism; 1956 Nov; 5(6 Part 2):940-6. PubMed ID: 13378063
    [No Abstract]   [Full Text] [Related]  

  • 22. Orinase: its mode of action and use in the treatment of diabetes mellitus.
    HENRY WL; THOMAS RF; ALEXIS CP; KIM JH; HALL AS
    J Natl Med Assoc; 1957 May; 49(3):139-41. PubMed ID: 13429340
    [No Abstract]   [Full Text] [Related]  

  • 23. [D 860 (rastinon) and BZ 55 (invenol) in oral therapy of diabetes mellitus].
    MELZER H; SACHSSE B
    Arztl Wochensch; 1956 Nov; 11(48):1058-62. PubMed ID: 13394470
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preliminary experience with peroral antidiabetic drugs].
    VERMEULEN A
    Belg Tijdschr Geneesk; 1956 Jul; 12(13):718-22. PubMed ID: 13341875
    [No Abstract]   [Full Text] [Related]  

  • 25. Experience with orinase in the management of adult diabetes.
    BRAVERMAN AE; DREY NW; SHERRY S
    Metabolism; 1956 Nov; 5(6 Part 2):911-8. PubMed ID: 13378060
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical experience and experimental studies with tolbutamide.
    CRAIG JW; MILLER M
    Diabetes; 1957; 6(3):280-2; discussion, 282-9. PubMed ID: 13427636
    [No Abstract]   [Full Text] [Related]  

  • 27. BZ-55 (CARBUTAMIDE): experimental and clinical studies of an oral antidiabetic agent.
    Can Med Assoc J; 1956 Jun; 74(12):957-98. PubMed ID: 13329939
    [No Abstract]   [Full Text] [Related]  

  • 28. [A new antidiabetic sulfamide; clinical indications and dosage].
    RAVINA A
    Presse Med (1893); 1956 Apr; 64(28):646-9. PubMed ID: 13335855
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antidiabetic effect of a new sulfonamide].
    TOLOMELLI E; PELLEGRINI R; POPPI A
    Riforma Med; 1956 Feb; 70(7):180-3. PubMed ID: 13311263
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ambulatory treatment of diabetics with a hypoglycemic sulfonamide].
    RAMEL C; HOFSTETTER JR
    Praxis; 1956 Apr; 45(16):365-9. PubMed ID: 13335688
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical experience with carbutamide and tolbutamide.
    COHN C; HEINEMAN A; LEVINE R; WEINSTEIN M
    Metabolism; 1956 Nov; 5(6 Part 2):972-7. PubMed ID: 13378067
    [No Abstract]   [Full Text] [Related]  

  • 32. [Oral treatment of diabetes mellitus with D-860, a new hypoglycemic but not sulfonamidic drug; clinical study of 90 cases].
    INTROZZI P; MARIGO S
    Prog Med (Napoli); 1956 Sep; 12(17):513-27. PubMed ID: 13379550
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of diabetes with oral hypoglycemic agents; trials of carbutamide and tolbutamide in fifty cases.
    OLSON OC
    Northwest Med; 1957 May; 56(5):588-95. PubMed ID: 13431043
    [No Abstract]   [Full Text] [Related]  

  • 34. CARBUTAMIDE and tolbutamide in diabetes.
    S Afr Med J; 1956 Dec; 30(51):1221-2. PubMed ID: 13391101
    [No Abstract]   [Full Text] [Related]  

  • 35. [BZ-55, a peroral antidiabetic remedy with a possible glucagon-restraining effect].
    ANDERSSON B
    Sven Lakartidn; 1956 Jan; 53(2):57-64. PubMed ID: 13311777
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of orinase in diabetes.
    BEASER SB
    Metabolism; 1956 Nov; 5(6 Part 2):933-9. PubMed ID: 13378062
    [No Abstract]   [Full Text] [Related]  

  • 37. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent studies relative to the treatment of diabetes; special reference to new oral antidiabetic drugs.
    WILLIAMS RH; HENLEY ED
    AMA Arch Intern Med; 1957 Apr; 99(4):501-18. PubMed ID: 13410156
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical experience with U-2043 (orinase).
    CLARKE WT
    Can Med Assoc J; 1956 Jun; 74(12):998. PubMed ID: 13329958
    [No Abstract]   [Full Text] [Related]  

  • 40. ORAL HYPOGLYCEMIC agents.
    Nutr Rev; 1956 Jul; 14(7):203-4. PubMed ID: 13335036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.